Oorsprong van het eerstegraads netwerk van Pierre Charneau
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
Theravectys SAS
 Theravectys SAS BiotechnologyHealth Technology Theravectys SAS provides biotechnology research services. It is working on the development of a therapeutic vaccine against HIV. The company was founded on May 17, 2005 and is headquartered in Paris, France.
5
| Holding Company | Biotechnology | 5 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Pierre Charneau via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| TENAX THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
International Drug Development Institute SA
 International Drug Development Institute SA Miscellaneous Commercial ServicesCommercial Services International Drug Development Institute SA engages in the provision of biostatistics and electronical-clinical solutions for phase I-IV clinical trials. It offers oncology clinical research, consultancy, clinical data management, data standards implementation and randomization services. The company was founded by Marc Buyse in 1991 and is headquartered in Louvain-la-Neuve, Belgium. | Miscellaneous Commercial Services | Director/Board Member | |
| Sanofi-Aventis Pharmaceuticals | Corporate Officer/Principal | ||
iTeos Therapeutics SA
 iTeos Therapeutics SA Pharmaceuticals: MajorHealth Technology iTeos Therapeutics SA engages in the discovery of immunomodulators for cancer therapy. It operates as a biotechnology company which focuses on targeting metabolism of the tumor microenvironment through development of small-molecule immunomodulators for cancer treatment. The firm develops small molecules designed to target the tumor microenvironment by inhibiting cancer-induced immune suppression. Targeting such resistance mechanisms will enhance the clinical efficacy of both standards of care treatments as well as the newer immunomodulatory therapies based on the blockade of immune checkpoints. The company was founded in 2011 by Michel Detheux and Benoit Van den Eynde and is headquartered in Gosselies, Belgium. | Pharmaceuticals: Major | Director/Board Member | |
Oxford BioTherapeutics Ltd.
 Oxford BioTherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Oxford BioTherapeutics Ltd. develops antibody-based medicines for oncology. The firm offers antibody-based cancer drugs with integrated diagnostics against novel targets. The company was founded by Christian Rohlff in 2003 and is headquartered in Abingdon, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Synergie Lyon Cancer
 Synergie Lyon Cancer Miscellaneous Commercial ServicesCommercial Services Synergie Lyon Cancer provides health care services. It focuses on research efforts on cancer escape, apoptosis and senescence and Immune surveillance. The company was founded in 2007 and is headquartered in Lyon, France. | Miscellaneous Commercial Services | President | |
| COMPUGEN LTD. | Biotechnology | Director/Board Member | |
| Aventis, Inc. | Chief Tech/Sci/R&D Officer | ||
Rhone Poulenc Rorer
 Rhone Poulenc Rorer Chemicals: SpecialtyProcess Industries Part of Solvay SA, Rhone Poulenc Rorer is a French pharmaceutical company that manufactures and distributes pharmaceutical products. | Chemicals: Specialty | Corporate Officer/Principal | |
| ADC THERAPEUTICS SA | Pharmaceuticals: Major | Director/Board Member | |
NETRIS Pharma SAS
 NETRIS Pharma SAS BiotechnologyHealth Technology NETRIS Pharma SAS develops targeted therapies for the treatment of cancer. The company is based in Lyon, France. The French company was founded in 2008 by Patrick Mehlen, Agnès Bernet. Patrick Mehlen has been the CEO since 2008. | Biotechnology | Chairman | |
| APREA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| ABIVAX | Pharmaceuticals: Other | Chief Tech/Sci/R&D Officer | |
| AB SCIENCE | Pharmaceuticals: Other | Corporate Officer/Principal | |
| Université de Rouen Normandie | College/University | Doctorate Degree | |
Institut de Recherches Internationales Servier
 Institut de Recherches Internationales Servier Miscellaneous Commercial ServicesCommercial Services Part of Servier SAS, Institut de Recherches Internationales Servier is a French company that provides scientific research and development services. The company is based in Suresnes, France. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| VALERIO THERAPEUTICS | Pharmaceuticals: Major | Director/Board Member | |
Melixia SA
 Melixia SA Miscellaneous Commercial ServicesCommercial Services Melixia SA operates as a business development consultant. The private company is based in Gland, Switzerland. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| University of Lausanne | College/University | Graduate Degree | |
Danish Silver A/S
 Danish Silver A/S Wholesale DistributorsDistribution Services Part of Fiskars Oyj Abp, Danish Silver A/S is a company that distributes gold, silver, platinum, and diamond jewelry, watches, cutlery, and hollowware items. The company is based in Copenhagen, Denmark. Gregory Pepin has been the CEO of the company since 2013. Danish Silver was acquired by Georg Jensen A/S, part of Fiskars Oyj Abp from October 01, 2023 on May 01, 2013. | Wholesale Distributors | Chief Executive Officer | |
| Vatea Fund | Chief Executive Officer | ||
EOS Investment Ltd.
 EOS Investment Ltd. Investment ManagersFinance Part of Vatea Fund, EOS Investment Ltd. is a Caymanian company that provides investment advice. The company is based in George Town, Cayman Islands. The company was founded by Gregory Pepin. | Investment Managers | Founder | |
Deltec Bank & Trust Ltd.
 Deltec Bank & Trust Ltd. Regional BanksFinance Deltec Bank & Trust Ltd. provides financial services with wealth planning and investment platform. It offers private banking, family office services, wealth, planning and structuring, investment management, fund services, merchant banking and corporate advisory, IPO advisory, and captive insurance. The company was founded by Clarence J. Dauphinot, Jr., Earl Elrick, and Angus Littlejohn in 1959 and is headquartered in Nassau, Bahamas. | Regional Banks | Corporate Officer/Principal | |
| FGP Capital France | Chief Executive Officer | ||
| Independent Wealth Management SA | Founder | ||
Hades Investment Ltd.
 Hades Investment Ltd. Investment ManagersFinance Hades Investment Ltd. provides investment advice. The private company is based in George Town, Cayman Islands. and has subsidiaries in Cayman Islands. | Investment Managers | Corporate Officer/Principal | |
| European Organisation for Research & Treatment of Cancer | Director/Board Member | ||
| TONY G CO-INVESTMENT HOLDINGS LTD. | Computer Communications | Director/Board Member | |
| Delchain Ltd. | Chairman | ||
| Cedrus Capital LLC | Chief Executive Officer | ||
| TRANSGENE | Biotechnology | Director/Board Member | |
| HALOZYME THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| CELATOR PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member | |
| University of Nice Sophia Antipolis | College/University | Doctorate Degree | |
| PIERIS PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member | |
| CELGENE | Biotechnology | Corporate Officer/Principal | |
Boehringer Ingelheim France SASU
 Boehringer Ingelheim France SASU Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim France SAS engages in the research, development, marketing, and distribution of pharmaceuticals. The company was founded on October 31, 1986 and is headquartered in Paris, France. | Pharmaceuticals: Major | Corporate Officer/Principal |
Statistieken
Internationaal
| Frankrijk | 14 |
| Verenigde Staten | 12 |
| Zwitserland | 6 |
| België | 4 |
| Verenigd Koninkrijk | 3 |
Sectoraal
| Health Technology | 20 |
| Commercial Services | 5 |
| Consumer Services | 5 |
| Finance | 4 |
| Process Industries | 3 |
Operationeel
| Director/Board Member | 19 |
| Corporate Officer/Principal | 14 |
| Independent Dir/Board Member | 9 |
| Chief Executive Officer | 5 |
| Founder | 4 |
Sterkste connecties
| Insiders | |
|---|---|
| Jean Bizzari | 24 |
| Gregory Pepin | 16 |
| Paul Gineste | 7 |
| Ye Tian | 1 |
| Jean Chalopin | 1 |
- Beurs
- Insiders
- Pierre Charneau
- Bedrijfsconnecties
